Cargando…

Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913306/ https://www.ncbi.nlm.nih.gov/pubmed/31849469 http://dx.doi.org/10.2147/IJN.S237537

Ejemplares similares

Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
por: Lee, Chen-Hung, et al.
Publicado: (2019)

Corrigendum to “Serial Changes of Neointimal Tissue after Everolimus-Eluting Stent Implantation in Porcine Coronary Artery: An Optical Coherence Tomography Analysis”
por: Won, Hoyoun, et al.
Publicado: (2019)

Nanoporous CREG-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries
por: Deng, Jie, et al.
Publicado: (2013)

Corrigendum to “Pioglitazone Attenuates Drug-Eluting Stent-Induced Proinflammatory State in Patients by Blocking Ubiquitination of PPAR”
por: Wang, Zhongxia, et al.
Publicado: (2019)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
por: Yang, Feng, et al.
Publicado: (2012)

Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
Publicado: (2019)

Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011)

Clinical Importance of the LDL-C/Apolipoprotein B Ratio for Neointimal Formation after Everolimus-Eluting Stent Implantations
por: Akutsu, Naotaka, et al.
Publicado: (2022)

Promoting vascular healing using nanofibrous ticagrelor-eluting stents
por: Lee, Cheng-Hung, et al.
Publicado: (2018)

Corrigendum: Comparison of Efficacy and Safety between First and Second Generation Drug-eluting Stents in Patients with Stable Coronary Artery Disease: A Single-center Retrospective Study
Publicado: (2021)

Corrigendum to: Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)
Publicado: (2019)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo
por: Diaz-Rodriguez, Sergio, et al.
Publicado: (2021)

The relationship between re-endothelialization and endothelial function after DES implantation: Comparison between paclitaxcel eluting stent and zotarolims eluting stent
por: Murase, Suguru, et al.
Publicado: (2014)

Corrigendum to “Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo”
por: Ho, Mao-Lin, et al.
Publicado: (2015)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
por: Yuan, Xiaohang, et al.
Publicado: (2023)

Evaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography
por: Feng, Tian, et al.
Publicado: (2013)

Corrigendum to “Antiadipogenic Effects of Aster glehni Extract: In Vivo and In Vitro Effects”
por: Lee, Heon-Myeong, et al.
Publicado: (2019)

Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine
por: Zhang, Qi, et al.
Publicado: (2007)

A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent
por: Chen, Yin, et al.
Publicado: (2021)

Macroporous Nanofibrous Vascular Scaffold with Improved Biodegradability and Smooth Muscle Cells Infiltration Prepared by Dual Phase Separation Technique [Corrigendum]
Publicado: (2022)

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014)

A two-layer skin construct consisting of a collagen hydrogel reinforced by a fibrin-coated polylactide nanofibrous membrane [Corrigendum]
Publicado: (2019)

Nanofibrous Vildagliptin/PLGA Membranes Accelerate Diabetic Wound Healing by Angiogenesis
por: Lee, Chen-Hung, et al.
Publicado: (2022)

Optical Coherence Tomographic Observation of Morphological Features of Neointimal Tissue after Drug-Eluting Stent Implantation
por: Lee, Seung-Yul, et al.
Publicado: (2014)

Succinobucol-Eluting Stents Increase Neointimal Thickening and Peri-Strut Inflammation in a Porcine Coronary Model
por: Watt, Jonathan, et al.
Publicado: (2013)

Carbon Quantum Dots: In vitro and in vivo Studies on Biocompatibility and Biointeractions for Optical Imaging [Corrigendum]
Publicado: (2022)

Corrigendum to “Fully Covered Metallic Stents for the Treatment of Benign Airway Stenosis”
por: Dahlqvist, Caroline, et al.
Publicado: (2018)

Propylthiouracil-coated biodegradable polymer inhibited neointimal formation and enhanced re-endothelialization after vascular injury
por: Chang, Shang-Hung, et al.
Publicado: (2018)

Telmisartan Loaded Nanofibers Enhance Re-Endothelialization and Inhibit Neointimal Hyperplasia
por: Lee, Chen-Hung, et al.
Publicado: (2021)

Influence of dual antiplatelet therapy duration on neointimal condition after second-generation drug-eluting stent implantation
por: Goryo, Yutaka, et al.
Publicado: (2021)

Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model
por: Ijichi, Takeshi, et al.
Publicado: (2021)

Hearing Protection Outcomes of Analog Electrode Arrays Coated with Different Drug-Eluting Polymer Films Implanted into Guinea Pig Cochleae [Corrigendum]
Publicado: (2021)

Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
por: Yamazaki, Shinji, et al.
Publicado: (2022)

Corrigendum to “Endothelial Gata6 deletion reduces monocyte recruitment and proinflammatory macrophage formation and attenuates atherosclerosis through Cmpk2-Nlrp3 pathways” [Redox Biol. 64 (2023) 102775]
por: Wu, Wenrun, et al.
Publicado: (2023)

Corrigendum to “Re-thinking benign inflammation of the lactating breast: Classification, prevention, and management”
Publicado: (2023)

Synthesis, construction, and evaluation of self-assembled nano-bacitracin A as an efficient antibacterial agent in vitro and in vivo [Corrigendum]
Publicado: (2019)

Synthesis, Construction, and Evaluation of Self-Assembled Nano-Bacitracin a as an Efficient Antibacterial Agent in vitro and in vivo [Corrigendum]
Publicado: (2020)

In vitro and in vivo Activity of Combinations of Polymyxin B with Other Antimicrobials Against Carbapenem-Resistant Acinetobacter baumannii [Corrigendum]
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_02v5o9kn96otnn33t51v8he3dk